8-K current report · filed Nov 4, 2026

Cushman & Wakefield Ltd. (CWK) 8-K Current Report: November 4, 2026

Item 2.02Item 7.01Item EX-99.1CWK overview

Short answer

Cushman & Wakefield Ltd. (CWK) filed an 8-K current report with the SEC on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Third-quarter 2026 financial results announced by Cushman & Wakefield.

Cushman & Wakefield Ltd. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Third-quarter 2026 financial results announced by Cushman & Wakefield
  • Press release Exhibit 99.1 contains the company’s reported operating and financial metrics

Item 7.01 · Regulation FD Disclosure

  • Third-quarter 2026 earnings conference call scheduled for November 4, 2026 at 9:00 a.m. Eastern Time
  • Investor webcast and slide presentation available through Cushman & Wakefield’s Investor Relations website
  • Audio replay and call transcript to follow, providing management commentary beyond the earnings release

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $2.8B, up 8%, led by Leasing up 15% and Capital markets up 18%, signaling broad commercial real estate recovery
  • Adjusted EBITDA $183.7M, up 15%, and Adjusted EPS $0.37, up 28%, despite diluted EPS remaining $0.22
  • Full-year 2026 Adjusted EPS growth guidance maintained at 18%-23%, reducing near-term guidance risk
  • Debt reduction lowered interest expense 12%; $150.0M 2028 Notes redemption eliminates nearest maturity, with no long-term maturities before 2030
  • Nine-month net income fell 17% to $92.2M, reflecting higher taxes, pension settlement costs and strategic investments despite Adjusted EBITDA growth roller coaster

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Cushman & Wakefield Ltd. 8-K filings

Get the next CWK 8-K as it lands

Follow CWK for push alerts, or ask the research agent what this filing means.